Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
52,406,487
-
Total 13F shares
-
47,343,776
-
Share change
-
+1,393,204
-
Total reported value
-
$233,886,428
-
Put/Call ratio
-
6.5%
-
Price per share
-
$4.94
-
Number of holders
-
135
-
Value change
-
+$26,350,036
-
Number of buys
-
62
-
Number of sells
-
62
Institutional Holders of 2seventy bio, Inc. - Common Stock, par value $0.0001 per share (TSVT) as of Q1 2025
As of 31 Mar 2025,
2seventy bio, Inc. - Common Stock, par value $0.0001 per share (TSVT) was held by
135 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,343,776 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, Beryl Capital Management LLC, BlackRock, Inc., MORGAN STANLEY, VANGUARD GROUP INC, Newtyn Management, LLC, BANK OF AMERICA CORP /DE/, BAKER BROS. ADVISORS LP, Man Group plc, and Casdin Capital, LLC.
This page lists
136
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.